222
Views
16
CrossRef citations to date
0
Altmetric
Original

Predictors of Benzodiazepine Discontinuation in Subjects Manifesting Complicated Dependence

, , &
Pages 499-510 | Published online: 03 Jul 2009

REFERENCES

  • American Psychiatric Association. Benzodiazepine Dependence, Toxicity and Abuse. APA Press, Washington, DC 1940
  • Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. British Journal of Addiction 1987; 82(6)665–671, [PUBMED], [INFOTRIEVE], [CSA]
  • Bruce T. J., Spiegel D. A., Gregg S. F., Nuzzarello A. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. American Journal of Psychiatry, 152(8)1156–1160
  • Bryant K. J., Rounsaville B., Spitzer R. L., Williams J. B. Reliability of dual diagnosis. Substance dependence and psychiatric disorders. The Journal of Nervous and Mental Disease 1992; 180(4)251–257, [PUBMED], [INFOTRIEVE]
  • Busto U. E., Romach M. K., Sellers E. M. Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. Journal of Clinical Psychopharmacology 1996; 16(1)51–57, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Charney D. A., Paraherakis A. M., Gill K. J. The treatment of sedative-hypnotic dependence: evaluating clinical predictors of outcome. Journal of Clinical Psychiatry 2000; 61(3)190–195, [PUBMED], [INFOTRIEVE]
  • Ciraulo D. A., Sands B. F., Shader R. Critical review of liability for benzodiazepine abuse among alcoholics. American Journal of Psychiatry 1998; 145(12)1501–1506
  • Comtois K. A., Cowley D. S., Dunner D. L., Roy-Byrne P. P. Relationship between borderline personality disorder and axis I diagnosis in severity of depression and anxiety. Journal of Clinical Psychiatry 1999; 60(11)752–758, [PUBMED], [INFOTRIEVE]
  • de l as, Cuevas C., Sanz E. J., de la Fuente J. A., Padilla J., Berenguer J. C. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 2002; 95(2)245–250
  • Derogatis L. R., Lipman R. S., Covi L. SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacology Bulletin 1973; 9(1)13–28, [PUBMED], [INFOTRIEVE]
  • Golombok S., Higgitt A., Fonagy P., Dodds S., Saper J., Lader M. A follow-up study of patients treated for benzodiazepine dependence. The British Journal of Medical Psychology 1987; 60(2)141–149, [PUBMED], [INFOTRIEVE]
  • Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90(5)607–614, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Griffiths R. R., Weerts E. M. Benzodiazepine self-administration in humans and laboratory animals—implications for problems of long-term use and abuse. Psychopharmacology 1997; 134(1)1–37, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Hall W., Teesson M., Lynskey M., Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-Being. Addiction 1999; 94(10)1541–1550, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kushner M. G., Abrams K., Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clinical Psychology Review 2000; 20(2)149–171, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Martínez-Cano H., de Iceta Ibánez de Gauna M., Vela-Bueno A., Wittchen H. U. DSM-III-R co-morbidity in benzodiazepine dependence. Addiction 1999; 94(1)97–107, [CROSSREF]
  • Merikangas K. R., Mehta R. L., Molnar B. E., Walters E. E., Swendsen J. D., Aguilar-Gaziola S., Bijl R., Borges G., Caraveo-Anduaga J. J., DeWit D. J., Kolody B., Vega W. A., Wittchen H U., Kessler R. C. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addictive Behaviors 1998; 23(6)893–907, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Regier D. A., Farmer M. E., Rae D. S., Locke B. Z., Keith S. J., Judd L. L., Goodwin F. K. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264(19)2511–2518, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Revicki D. A., Turner R., Martindale J. J. Reliability and validity of a health-related quality of life-battery for evaluating outpatient antidepressant treatment. Quality of Life Research 1992; 1: 257–266, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Rickels K., Schweizer E., Case G. W., Garcia-Espana F. Risk factors in benzodiazepine misuse and dependence. Benzodiazepine dependence, withdrawal severity, and clinical outcome: effects of personality. Psychopharmacology Bulletin 1988; 24(3)415–420, [PUBMED], [INFOTRIEVE]
  • Rickels K., Schweizer E., Case W. G., Greenblatt D. J. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Archives of General Psychiatry 1990; 47(10)899–907, [PUBMED], [INFOTRIEVE]
  • Rickels K., DeMartinis N., García-España F., Greenblatt D. J., Mandos L. A., Rynn M. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy. American Journal of Psychiatry 2000; 157(12)1973–1979, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Romach M., Busto U., Somer G., Kaplan H. L., Sellers E. Clinical aspects of chronic use of alprazolam and lorazepam. American Journal of Psychiatry 1995; 152(8)1161–1167, [PUBMED], [INFOTRIEVE]
  • Ross H. E. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction 1993; 88(2)209–218, [PUBMED], [INFOTRIEVE]
  • Saunders J. B., Aasland O. G., Babor T. F., de la Fuente J. R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. II. Addiction 1993; 88(6)791–804, [PUBMED], [INFOTRIEVE]
  • Schweizer E., Rickels K., De Martinis N., Case G., Garcia-Espana F. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients. Psychological Medicine 1998; 28(3)713–720, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Spitzer R., Williams J. Structured Clinical Interview for DSM-III-R, Patient Version. Biometric Research Department, New York State Psychiatric Institute, New York 1985
  • Spitzer R., Williams J., Gibbon M. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). American Psychiatric Association, Washington, DC 1990
  • Streiner D., Norman G. Health Measurement Scales. A Practical Guide to Their Development and Use. Oxford University Press, Oxford 1989
  • Swendsen J. D., Merikangas K. R. The comorbidity of depression and substance use disorders. Clinical Psychology Review 2000; 20(2)173–189, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Tabachnick B. G., Fidell L. S. Using Multivariate Statistics, 3rd ed. Harper Collins College Publishers, New York 1996; 575–633
  • Tyrer P. Risks of dependence on benzodiazepine drugs: the importance of patient selection. British Medical Journal 1989; 298(102)104–105
  • Vorma H., Naukkarinen H., Sarna S., Kuoppasalmi K. Treatment of outpatients with complicated benzodiazepine dependence: Comparison of two approaches. Addiction 2002; 97(7)851–860, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Vorma H., Naukkarinen H., Sarna S., Kuoppasalmi K. Long-term outcome after benzodiazepine withdrawal treatment in subjects with complicated dependence. Drug and Alcohol Dependence 2003; 70: 309–314, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Wolf B., Grohmann R., Biber D., Brenner P. M., Ruther E. Benzodiazepine abuse and dependence in psychiatric inpatients. Pharmacopsychiatry 1989; 22(2)54–60, [PUBMED], [INFOTRIEVE]
  • Woods J. H., Katz J. L., Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacological Reviews 1992; 44(2)151–347, [PUBMED], [INFOTRIEVE]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.